Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease. Lee SD, Singla A, Harper J, Barahimi M, et al. Dig Dis Sci 2022;67:4043-4048.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee SD, Singla A, Harper J, Barahimi M, et al. Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease. Dig Dis Sci 2022;67:4043-4048.
PMID: 35288831